Search results
Are you a Medicare, Social Security recipient planning a move? Here's what you should know
The Oklahoman via Yahoo News· 10 hours agoYou can also switch Part D or Medicare Advantage plans during open enrollment, which runs each year...
Albertsons accepting supplemental health benefits with new partnership
Grocery Dive via Yahoo Finance· 5 days agoNearly all (99.9%) Medicare Advantage plans offered supplemental benefits in 2023, compared with 73%...
Best Medicare Supplement Insurance Companies in 2024 - NerdWallet
Nerdwallet· 6 days agoFind the best Medigap insurance company for your needs and your budget.
Encompass Health Corporation (NYSE:EHC) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 hours agoEncompass Health Corporation (NYSE:EHC) Q1 2024 Earnings Call Transcript April 25, 2024 Encompass...
$10 Million Last You This Long If You Retire at 40
SmartAsset via Yahoo Finance· 1 day agoRetiring at 40 really can mean enjoying retirement in your (relative) youth. The question is, what does it take to make that possible? If you are lucky...
CENTENE CORPORATION REPORTS FIRST QUARTER 2024 RESULTS
FOX 4 Kansas City· 4 days ago2024 adjusted diluted EPS of $2.26, up over 7% from $2.11 in the first quarter of 2023. Increases...
Healthy travel tips for older travelers - East Idaho News
EastIdahoNews.com· 3 days agoWhat tips can you offer retirees with health issues who are planning some trips? Before setting out,...
Cetera Trust Company N.A Buys New Holdings in Humana Inc. (NYSE:HUM)
ETF DAILY NEWS· 7 days agoCetera Trust Company N.A bought a new stake in shares of Humana Inc. (NYSE:HUM – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities ...
Op-ed: Here are 6 health-care stocks to watch now, amid a bumpy recovery
CNBC· 6 days agoHealth care, long an ailing stock market sector, has recovered over the past six months, with...
Humana (NYSE:HUM) PT Lowered to $381.00
ETF DAILY NEWS· 7 days agoHumana (NYSE:HUM – Get Free Report) had its price objective lowered by research analysts at Jefferies Financial Group from $411.00 to $381.00 in a note issued to investors on Monday, Benzinga ...